Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:933-939
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mair, D. D.
Right arrow Articles by Danielson, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mair, D. D.
Right arrow Articles by Danielson, G. K.

CLINICAL STUDY: PEDIATRIC CARDIOLOGY

The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients

Douglas D. Mair, MD, FACC*, Francisco J. Puga, MD, FACC{dagger} and Gordon K. Danielson, MD, FACC{dagger}

* Section of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota, USA
{dagger} Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA

Manuscript received June 21, 2000; revised manuscript received September 20, 2000, accepted November 3, 2000.

Reprint requests and correspondence: Dr. Douglas D. Mair, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905
mair.douglas{at}mayo.edu

OBJECTIVES

We assessed the operative and late mortality and the present clinical status of 216 patients with tricuspid atresia who had a nonfenestrated Fontan procedure performed at the Mayo Clinic in the 25-year period 1973 to 1998.

BACKGROUND

The Fontan operation eliminates the systemic hypoxemia and ventricular volume overload characteristic of prior forms of palliation. However, it originally did so at the cost of systemic venous and right atrial hypertension, and the long-term effects of this "price" were unknown when the procedure was initially proposed.

METHODS

We reviewed the clinical records of the 216 patients retrospectively. These were arbitrarily grouped into early (1973 through 1980), middle (1981 through 1987) and late (1988 through 1997) surgical eras. Patient outcome was also analyzed according to age at surgery. Operative and late mortality rates were determined and present clinical status was ascertained in 167 of 171 surviving patients.

RESULTS

Overall survival was 79%. Operative mortality steadily declined and was 2% (one of 58 patients) during the most recent decade. Late survival also continues to improve. Age at operation had no effect on operative mortality, and late mortality was significantly increased only in patients who were operated on at age 18 years or older. Eighty-nine percent of surviving patients are currently in New York Heart Association class I or II.

CONCLUSIONS

The initial 25-year experience with the nonfenestrated Fontan procedure for tricuspid atresia has been gratifying, with most survivors now leading lives of good quality into adulthood. These results justify continued application of this procedure for children born with tricuspid atresia.

Abbreviations and Acronyms
  LV = left ventricular
  NYHA = New York Heart Association
  PA = pulmonary artery
  RA = right atrium
  RV = right ventricle, right ventricular




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. Silvilairat, Y. Pongprot, R. Sittiwangkul, S. Woragidpoonpol, S. Chuaratanaphong, and W. Nawarawong
Factors Influencing Survival in Patients After Bidirectional Glenn Shunt
Asian Cardiovasc Thorac Ann, October 1, 2008; 16(5): 381 - 386.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Camposilvan, O. Milanesi, G. Stellin, A. Pettenazzo, L. Zancan, and L. D'Antiga
Liver and Cardiac Function in the Long Term After Fontan Operation
Ann. Thorac. Surg., July 1, 2008; 86(1): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. K. Whitehead, K. Pekkan, H. D. Kitajima, S. M. Paridon, A. P. Yoganathan, and M. A. Fogel
Nonlinear Power Loss During Exercise in Single-Ventricle Patients After the Fontan: Insights From Computational Fluid Dynamics
Circulation, September 11, 2007; 116(11_suppl): I-165 - I-171.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. J. Bartz, D. J. Driscoll, J. A. Dearani, F. J. Puga, G. K. Danielson, P. W. O'Leary, M. G. Earing, C. A. Warnes, D. O. Hodge, and F. Cetta
Early and Late Results of the Modified Fontan Operation for Heterotaxy Syndrome: 30 Years of Experience in 142 Patients
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2301 - 2305.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. J. Guleserian, L. B. Armsby, R. R. Thiagarajan, P. J. del Nido, and J. E. Mayer Jr
Natural History of Pulmonary Atresia With Intact Ventricular Septum and Right-Ventricle-Dependent Coronary Circulation Managed by the Single-Ventricle Approach
Ann. Thorac. Surg., June 1, 2006; 81(6): 2250 - 2258.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Alphonso, M. Baghai, P. Sundar, R. Tulloh, C. Austin, and D. Anderson
Intermediate-term outcome following the fontan operation: a survival, functional and risk-factor analysis
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 529 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. T. Mahle, J. M. Forbess, P. M. Kirshbom, A. R. Cuadrado, J. M. Simsic, and K. R. Kanter
Cost-utility analysis of salvage cardiac extracorporeal membrane oxygenation in children
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1084 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. T. Nicolas, C. Hills, J. H. Moller, C. B. Huddleston, and M. C. Johnson
Early Outcome After Glenn Shunt and Fontan Palliation and the Impact of Operation During Viral Respiratory Season: Analysis of a 19-year Multi-Institutional Experience
Ann. Thorac. Surg., February 1, 2005; 79(2): 613 - 617.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Petko, R. J. Myung, G. Wernovsky, M. I. Cohen, J. Rychik, S. C. Nicolson, J. W. Gaynor, and T. L. Spray
Surgical reinterventions following the Fontan procedure
Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 255 - 259.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Khambadkone, J. Li, M.R. de Leval, S. Cullen, J.E. Deanfield, and A.N. Redington
Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type Operation
Circulation, July 1, 2003; 107(25): 3204 - 3208.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. M. Burkhart, J. A. Dearani, D. D. Mair, C. A. Warnes, C. C. Rowland, H. V. Schaff, F. J. Puga, and G. K. Danielson
The modified Fontan procedure: Early and late results in 132 adult patients
J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1252 - 1259.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Levy, C. Danel, A.-M. Laval, F. Leca, P. R. Vouhe, and D. Israel-Biet
Nitric oxide synthase expression by pulmonary arteries: A predictive marker of Fontan procedure outcome?
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1083 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. G. Seipelt, A. Franke, J. F. Vazquez-Jimenez, P. Hanrath, G. von Bernuth, B. J. Messmer, and E. G. Muhler
Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches
Ann. Thorac. Surg., August 1, 2002; 74(2): 556 - 562.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement